“…The accuracy of the data provided by this revisited CBA-N2a, relies, in part, on the availability of five viability controls, i.e., RCV, COV − , COV + , QCOV − and QCOV + that were established throughout the various stages of CBA-N2a in order to verify: (i) the initial (RCV control) and final viability of N2a cells (COV − controls), (ii) the efficiency of O/V treatment (COV + controls) and (iii) the detection of the specific mode of action of VGSC activators vs. inhibitors (QCOV − and QCOV + controls). If the use of percentages is recurrent in most studies to express cell viability results [7,8,32,33,36,37,43,46,53,59,62,63,[66][67][68]70,73,74,76,81,83,85,87,88,90,91,95,97,103,[106][107][108][109][110][111][112], the originality of our revisited CBA-N2a is to recommend the use of absorbance data by establishing a RCV control that characterizes the baseline viability of N2a cell layer prior to O/V treatment and toxin exposure. This RCV control serves as a reference from which all other viability controls as well as viability data of standard and samples depend.…”